Baxter International, an industry leader in pharmaceuticals and biotechnology acquires Baxa Corporation, a privately held nutrition and IV delivery company. This acquisition will enhance Baxter's capabilities to produce industry leading technology and distribute to a larger market more effectively. Publicly traded, Baxter International has been providing solutions to the medical industry for over 80 years.
Specializing in treatment of immune disorders, infectious diseases, kidney disease, and other chronic and acute medical conditions, Baxter has stood at the forefront of IV nutrition and delivery systems. The cutting edge technologies such as multichamber containers and admixing have revolutionized delivery systems while a complete line of nutrient infused fluids have helped treat and sustain afflicted patients globally.
In order to further the development of nutrition products, Baxa has been joined into an already groundbreaking company structure. Having developed safe and effective products in the private sector for years, it is believed that Baxa will be a strong asset for Baxter International's ongoing success.
No comments:
Post a Comment